Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexa-Myositis Trial
NL-OMON25817Recruiting
- Sponsor
- Princess Beatrix Spierfonds
- Start
- Jul 2001
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in polymyositis (PM), dermatomyositis (DM) and Myositis comparing Dexamethasone pulse therapy with Prednisolone (2 arms). Primary endpoints: Combined clinical outcome scale, Remission and relapse outcomes and 1 more. Started Jul 2001; status: recruiting.
02
Drugs
dexamethasoneprednisolone
03
Conditions
polymyositis (PM)dermatomyositis (DM)Myositis
Beyond the preview
Go deeper on NL-OMON25817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25817.